The "Nasal Drug Delivery Technology - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
The Nasal Drug Delivery Technology market worldwide is projected to grow by US$25.4 Billion, driven by a compounded growth of 6.2%.
Nasal Sprays, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$39.9 Billion by the year 2025, Nasal Sprays will bring in healthy gains adding significant momentum to global growth.
Representing the developed world, the United States will maintain a 7.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$1.1 Billion to the region's size and clout in the next 5 to 6 years. Over US$1.2 Billion worth of projected demand in the region will come from the rest of the European markets. In Japan, Nasal Sprays will reach a market size of US$3.2 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 5.9% over the next couple of years and add approximately US$4.4 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.
Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include:
- 3M Company
- Aegis Therapeutics LLC
- Aptargroup, Inc.
- AstraZeneca PLC
- GlaxoSmithKline PLC
- Johnson & Johnson
- Merck & Co., Inc.
- Novartis International AG
-
Pfizer, Inc.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Global Competitor Market Shares
- Nasal Drug Delivery Technology Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
IV. COMPETITION
V. CURATED RESEARCH
For more information about this report visit https://www.researchandmarkets.com/r/jwdkpp
View source version on businesswire.com: https://www.businesswire.com/news/home/20200330005261/en/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.